Shandong: restrict the use of 994 drugs that have not won the bid!

Yesterday, Shandong provincial drug centralized purchase platform issued a notice on listing 994 drugs in the list of restricted use catalogue of drugs purchased by medical institutions in Shandong Province The following is the full text of the announcement: relevant units: according to the notice of Shandong health and Family Planning Commission on the implementation of the new round of centralized drug procurement results (lwyzf [2016] No 2) and the relevant provisions of the procurement documents, the products that are not winning the bid in the centralized drug procurement of our province are listed in the restricted use catalogue (see the attached table for details) Publicity period: from November 14, 2018 to 17:00 on November 16, 2018 If you have any objection to the publicity content, please submit the materials (with electronic seal) through "Shandong drug centralized purchase platform" - "complaint and grievance management" within the publicity period The deadline is 17:00 on November 16, 2018, which will not be accepted after the deadline The submitted materials shall be true and effective, and no malicious complaints shall be made Consultation Tel.: 0531-67873123, 67873167 (acceptance Hall) 0531-67873161, 67873135 (Technology) Shandong public resources trading center November 14, 2018 attachment list: list of unsuccessful products in centralized drug procurement of Shandong Province in restricted use catalogue